Premium
Monopar Therapeutics Inc (MNPR)
NASDAQ
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | Dr. Chandler D. RobinsonCo-Founder, CEO, President & Director | -1,97k | 108,05k | Derivative Exercise and Sale | 54,79 | 153,29k | - |
| 2026-03-31 | Dr. Chandler D. RobinsonCo-Founder, CEO, President & Director | 4,76k | 0,00 | Derivative Exercise and Retained Stock | - | 153,29k | 3,20% |
| 2026-03-31 | Mr. Andrew J. CittadineCOO | -1,57k | 86,08k | Derivative Exercise and Sale | 54,79 | 52,67k | - |
| 2026-03-31 | Mr. Andrew J. CittadineCOO | 1,94k | 0,00 | Derivative Exercise and Retained Stock | - | 52,67k | 3,83% |
| 2025-12-31 | Mr. Andrew J. CittadineCOO | 2,44k | 0,00 | Derivative Exercise and Retained Stock | - | 50,73k | 5,05% |
| 2025-12-31 | Mr. Andrew J. CittadineCOO | -1,89k | 123,35k | Derivative Exercise and Sale | 65,30 | 50,73k | - |
| 2025-12-31 | Dr. Chandler D. RobinsonCo-Founder, CEO, President & Director | 6,17k | 0,00 | Derivative Exercise and Retained Stock | - | 85,72k | 7,75% |
| 2025-12-31 | Dr. Chandler D. RobinsonCo-Founder, CEO, President & Director | -2,56k | 167,04k | Derivative Exercise and Sale | 65,30 | 85,72k | - |
| 2025-12-26 | Mr. Quan Anh VuCFO, Principal accounting officer, Principal financial officer, Secretary & Treasurer | 1,50k | 104,93k | Achat | 69,95 | 1,50k | - |
| 2025-12-18 | Mr. Arthur J. KlausnerIndependent Director | -5,12k | 343,89k | Vente | 67,06 - 68,09 | 8,76k | -36,89% |
| 2025-12-16 | Tactic Pharma LLCSociété | -43,50k | 0,00 | Other Disposition | - | 567,58k | -7,12% |
| 2025-09-30 | Mr. Andrew J. CittadineCOO | 2,43k | 0,00 | Derivative Exercise and Retained Stock | - | 48,29k | 5,30% |
| 2025-09-30 | Mr. Andrew J. CittadineCOO | -1,90k | 154,85k | Derivative Exercise and Sale | 81,67 | 48,29k | - |
| 2025-09-30 | Dr. Chandler D. RobinsonCo-Founder, CEO, President & Director | 6,08k | 0,00 | Derivative Exercise and Retained Stock | - | 79,55k | 8,28% |
| 2025-09-30 | Dr. Chandler D. RobinsonCo-Founder, CEO, President & Director | -2,65k | 216,10k | Derivative Exercise and Sale | 81,67 | 79,55k | - |
| 2025-09-24 | Tactic Pharma LLCSociété | -550,23k | 35,00M | Vente | 63,61 | 883,11k | -38,39% |
| 2025-07-14 | Ms. Kim R. TsuchimotoDirector | -8,90k | 356,13k | Derivative Exercise and Sale | 0,01 - 40,00 | 11,49k | - |
| 2025-07-14 | Dr. Christopher M. StarrCo-Founder & Independent Executive Chairman of the Board | -16,80k | 671,94k | Derivative Exercise and Sale | 0,01 - 40,00 | 15,05k | - |
| 2025-07-14 | Dr. Chandler D. RobinsonCo-Founder, CEO, President & Director | -16,80k | 671,94k | Derivative Exercise and Sale | 0,01 - 40,00 | 73,47k | - |
| 2025-06-30 | Dr. Chandler D. RobinsonCo-Founder, CEO, President & Director | 7,48k | 0,00 | Derivative Exercise and Retained Stock | - | 73,47k | 11,33% |
| 2025-06-30 | Dr. Chandler D. RobinsonCo-Founder, CEO, President & Director | -5,87k | 209,85k | Derivative Exercise and Sale | 35,78 | 73,47k | - |
| 2025-06-30 | Mr. Andrew J. CittadineCOO | 3,87k | 0,00 | Derivative Exercise and Retained Stock | - | 45,86k | 9,22% |
| 2025-06-30 | Mr. Andrew J. CittadineCOO | -2,99k | 106,98k | Derivative Exercise and Sale | 35,78 | 45,86k | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
